Thank you, David Ford, for your commitment to raising awareness about the importance of #prostatecancer testing and for spotlighting #EpiSwitchPSE! #EarlyDetectionSavesLives #GetScreened
Over the past year, my efforts to promote prostate cancer screening have significantly increased, especially as new legislation aims to remove barriers to screening. Partnering with Glue Advertising & Public Relations, we’ve highlighted Oxford BioDynamics’ EpiSwitch PSE, a simple blood test that, when combined with the PSA test, boosts screening accuracy from 55% to 94%. This advancement offers clearer insights into prostate health with less hassle. If you’re hesitant about screening, innovations like this make it easier than ever to #getscreened. ACS.org Don’t delay—plan your screening today.